Author

Sharad Tikkiwal

Observed name: Tikkiwal, Sharad

Observed institution: SMS Medical College

OpenAlex ID: A5000000717

Coexistence of allergic rhinitis and asthma in Indian patients: The CARAS survey

2019 · Meena Lopez, Vikram Jaggi, et al. · Lung India · 40

Real-world evaluation of the clinical safety and efficacy of fluticasone/formoterol FDC via the Revolizer® in patients with persistent asthma in India

2019 · Aloke Ghoshal, Pradyut Waghray, et al. · Pulmonary Pharmacology & Therapeutics · 7

Salmeterol/fluticasone through breath-actuated inhaler versus pMDI: a randomized, double-blind, 12 weeks study

2015 · Raja Dhar, Sundeep Salvi, et al. · Journal of Asthma · 7

Efficacy and safety of glycopyrronium/formoterol delivered via a dry powder inhaler in patients with moderate to severe chronic obstructive pulmonary disease: Results from a multi-centre, open-label, randomised study

2022 · Sundeep Salvi, Anand Kumar, et al. · Lung India · 3

Luftsichel sign

2012 · Sheetu Singh, Nishtha Singh, et al. · Lung India · 2

Comparison of efficacy and safety of twice-daily Glycopyrronium/Formoterol combination with once-daily Glycopyrronium in patients with moderate to severe COPD

2019 · Sundeep Salvi, Anand Kumar, et al. · European Respiratory Journal · 1

Clinical evaluation of fluticasone/formoterol twice daily delivered via a single dose dry powder inhaler in patients with persistent asthma

2016 · Pradyut Waghray, Mahip Saluja, et al. · European Respiratory Journal · 1

Comparison of HFA salmeterol-fluticasone (SFC) combination when given through breath actuated inhaler (BAI) and pressurised meter dose inhaler (pMDI) in patients with moderate-to-severe asthma

2013 · Jaideep Gogtay, Sundeep Salvi, et al. · European Respiratory Journal

Works count: 9

Citation count: 61

H-index: 3

I10-index: 1